CYP 4.00% 24.0¢ cynata therapeutics limited

Ann: Approval of Clinical Trial of CYP-001 in Kidney Transplant, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,227 Posts.
    lightbulb Created with Sketch. 482
    ... yes indeedily ... thank you to the Leiden University Medical Centre for fully funding and running this trial ...

    Allowing Cynata to retain its $A 16 cash balance , almost 10 cents per share ...

    ... a happy start to the week for us Cynutters ...
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.